Concepedia

A. Rob P.M. Valentijn

AR

Statistics

Publications

49

Citations

4.2K

H-Index

30

Active since

1988

Affiliations

Leiden University Medical Center(Current)

Leiden University

ISA Pharmaceuticals (Netherlands)

Centre for Human Drug Research

Institute of Haematology and Blood Transfusion

A. Rob P.M. Valentijn is an author at Leiden University Medical Center specializing in medicine, oncology, and immunology.

Publications per year

1988–2025

49

Publications

49

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

Gemma G. Kenter, Marij J.P. Welters, A. Rob P.M. Valentijn et al. · New England Journal of Medicine · 2009 · 1.1K citations · Full text

, , +17

Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine

Marij J.P. Welters, Gemma G. Kenter, Sytse J. Piersma et al. · Clinical Cancer Research · 2008 · 368 citations · Full text

, , +17

Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity

Gemma G. Kenter, Marij J.P. Welters, A. Rob P.M. Valentijn et al. · Clinical Cancer Research · 2008 · 309 citations · Full text

, , +17

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

Marij J.P. Welters, Gemma G. Kenter, Peggy J. de Vos van Steenwijk et al. · Proceedings of the National Academy of Sciences · 2010 · 238 citations · Full text

, , +17

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

Mariëtte I.E. van Poelgeest, Marij J.P. Welters, Edith M.G. van Esch et al. · Journal of Translational Medicine · 2013 · 187 citations · Full text

, , +17

1–5 of 49